StoneX(SNEX) - 2023 Q2 - Earnings Call Transcript

I would now like to hand the conference over to your speaker today, CFO, Bill Dunaway. Please go ahead. Moving to Slide 4, which shows the same data for the trailing 12 months. Over this longer period and despite more challenging comparisons now coming to date, we realized strong revenue growth across all products, except listed and OTC derivatives, which were up only single digits. Securities was up 57%, due somewhat to the accounting impact of the interest mentioned earlier and physical contracts were up ...